0 followers
Tiaki Therapeutics is developing first-in-class therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function.
Industries
Headquarters
Employees
Links
0 members
Bio-Rad Laboratories
11 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies